Company · CIK 1841387

# Candel Therapeutics, Inc.

| CIK | [1841387](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001841387) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | CADL (Nasdaq) |
| First annual or quarterly report | 2021-09-08 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-289595 | Shelf Effective | 2025-08-14 | 2026-02-20 | 4 |
| 333-266605 | Shelf Effective | 2022-08-05 | 2025-06-24 | 7 |
| 333-257444 | IPO Final prospectus | 2021-06-25 | 2021-07-28 | 6 |

## Filings

 18

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-02-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312526061389/0001193125-26-061389-index.htm) Shelf takedown | 333-289595 | 0001193125-26-061389 |
| 2026-02-19 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312526059514/0001193125-26-059514-index.htm) Shelf takedown | 333-289595 | 0001193125-26-059514 |
| 2025-08-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1841387/999999999525002727/9999999995-25-002727-index.htm) Declared effective | 333-289595 | 9999999995-25-002727 |
| 2025-08-14 | [S-3](https://www.sec.gov/Archives/edgar/data/1841387/000119312525180411/0001193125-25-180411-index.htm) Shelf registered | 333-289595 | 0001193125-25-180411 |
| 2025-06-24 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312525145401/0001193125-25-145401-index.htm) Shelf takedown | 333-266605 | 0001193125-25-145401 |
| 2024-12-13 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312524278628/0001193125-24-278628-index.htm) Shelf takedown | 333-266605 | 0001193125-24-278628 |
| 2024-12-12 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312524277171/0001193125-24-277171-index.htm) Shelf takedown | 333-266605 | 0001193125-24-277171 |
| 2024-05-24 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312524146526/0001193125-24-146526-index.htm) Shelf takedown | 333-266605 | 0001193125-24-146526 |
| 2024-02-13 | [424B5](https://www.sec.gov/Archives/edgar/data/1841387/000119312524032997/0001193125-24-032997-index.htm) Shelf takedown | 333-266605 | 0001193125-24-032997 |
| 2022-08-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1841387/999999999522002371/9999999995-22-002371-index.htm) Declared effective | 333-266605 | 9999999995-22-002371 |
| 2022-08-05 | [S-3](https://www.sec.gov/Archives/edgar/data/1841387/000119312522213718/0001193125-22-213718-index.htm) Shelf registered | 333-266605 | 0001193125-22-213718 |
| 2021-07-28 | [424B4](https://www.sec.gov/Archives/edgar/data/1841387/000119312521227369/0001193125-21-227369-index.htm) Final prospectus | 333-257444 | 0001193125-21-227369 |
| 2021-07-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1841387/999999999521002918/9999999995-21-002918-index.htm) Declared effective | 333-257444 | 9999999995-21-002918 |
| 2021-07-26 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1841387/000119312521223611/0001193125-21-223611-index.htm) Amendment | 333-257444 | 0001193125-21-223611 |
| 2021-07-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1841387/000119312521219850/0001193125-21-219850-index.htm) Amendment | 333-257444 | 0001193125-21-219850 |
| 2021-07-16 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1841387/000119312521216891/0001193125-21-216891-index.htm) Amendment | 333-257444 | 0001193125-21-216891 |
| 2021-06-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1841387/000119312521200639/0001193125-21-200639-index.htm) Registration filed | 333-257444 | 0001193125-21-200639 |
| 2021-02-16 | [DRS](https://www.sec.gov/Archives/edgar/data/1841387/000095012321002069/0000950123-21-002069-index.htm) Draft made public | 377-04235 | 0000950123-21-002069 |

[All filings of this company](https://equitycapital.markets/filings?cik=1841387) · [CSV](https://equitycapital.markets/filings.csv?cik=1841387)

---
Source page: https://equitycapital.markets/company/1841387 · Data: U.S. SEC EDGAR · CC BY 4.0